| 1ZGV: reference: Development of an oxazolopyridine series of dual thrombin/factor Xa inhibitors via structure-guided lead optimization., Deng JZ, McMasters DR, Rabbat PM, Williams PD, Coburn CA, Yan Y, Kuo LC, Lewis SD, Lucas BJ, Krueger JA, Strulovici B, Vacca JP, Lyle TA, Burgey CS, Bioorg Med Chem Lett 2005 Oct 15;15(20):4411-6. PMID: 16137886 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).